Peter Hiatt

3.7k total citations · 1 hit paper
35 papers, 2.7k citations indexed

About

Peter Hiatt is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Molecular Biology. According to data from OpenAlex, Peter Hiatt has authored 35 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 12 papers in Epidemiology and 3 papers in Molecular Biology. Recurrent topics in Peter Hiatt's work include Cystic Fibrosis Research Advances (19 papers), Neonatal Respiratory Health Research (11 papers) and Tracheal and airway disorders (11 papers). Peter Hiatt is often cited by papers focused on Cystic Fibrosis Research Advances (19 papers), Neonatal Respiratory Health Research (11 papers) and Tracheal and airway disorders (11 papers). Peter Hiatt collaborates with scholars based in United States, Georgia and Australia. Peter Hiatt's co-authors include Bonnie W. Ramsey, Margaret Rosenfeld, Karen McCoy, Sharon McNamara, Julia Emerson, Robert G. Castile, Jane L. Burns, Ronald L. Gibson, Pedro A. Piedra and Arnold L. Smith and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, PEDIATRICS and Journal of Clinical Microbiology.

In The Last Decade

Peter Hiatt

31 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation

2014 277 citations K. De Boeck, À. Munck et al. Journal of Cystic Fibrosis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Hiatt United States	20	2.1k	778	542	303	226	35	2.7k
Rosemary Carzino Australia	19	1.9k 0.9×	459 0.6×	476 0.9×	250 0.8×	152 0.7×	40	2.3k
Svend Stenvang Pedersen Denmark	27	901 0.4×	754 1.0×	472 0.9×	343 1.1×	116 0.5×	57	2.0k
Kelly Otto United States	9	1.7k 0.8×	391 0.5×	263 0.5×	220 0.7×	107 0.5×	13	1.9k
Hanne Vebert Olesen Denmark	24	1.5k 0.7×	336 0.4×	347 0.6×	92 0.3×	179 0.8×	73	2.2k
D. Elizabeth Tullis Canada	20	960 0.5×	334 0.4×	483 0.9×	190 0.6×	162 0.7×	34	1.7k
Douglas B. Hornick United States	19	465 0.2×	287 0.4×	265 0.5×	242 0.8×	124 0.5×	36	1.1k
T. Pressler Denmark	19	784 0.4×	399 0.5×	210 0.4×	115 0.4×	202 0.9×	56	1.3k
Elliott C. Dasenbrook United States	20	1.3k 0.6×	361 0.5×	344 0.6×	107 0.4×	412 1.8×	39	1.6k
Marianne Skov Denmark	28	1.7k 0.8×	505 0.6×	274 0.5×	89 0.3×	860 3.8×	89	2.5k
Lisa Cariani Italy	19	373 0.2×	344 0.4×	358 0.7×	211 0.7×	219 1.0×	45	1.2k

Countries citing papers authored by Peter Hiatt

Since Specialization

Citations

This map shows the geographic impact of Peter Hiatt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hiatt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hiatt more than expected).

Fields of papers citing papers by Peter Hiatt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Hiatt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hiatt. The network helps show where Peter Hiatt may publish in the future.

Co-authorship network of co-authors of Peter Hiatt

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Hiatt. A scholar is included among the top collaborators of Peter Hiatt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Hiatt. Peter Hiatt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Peloquin, Charles A., et al.. (2021). Administration and monitoring of clofazimine for NTM infections in children with and without cystic fibrosis. Journal of Cystic Fibrosis. 21(2). 348–352. 7 indexed citations

Boeck, K. De, À. Munck, Seth Walker, et al.. (2014). Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation. Journal of Cystic Fibrosis. 13(6). 674–680. 277 indexed citations breakdown →

Singh, Shipra, et al.. (2012). Efficacy of Ivacaftor in a Child with Cystic Fibrosis, End-Stage Lung Disease, and Cepacia Syndrome. Pediatric Allergy Immunology and Pulmonology. 25(4). 231–233. 2 indexed citations

Brumback, Lyndia C., Stephanie D. Davis, Gwendolyn S. Kerby, et al.. (2012). Lung function from infancy to preschool in a cohort of children with cystic fibrosis. European Respiratory Journal. 41(1). 60–66. 18 indexed citations

Ren, Clement L., Margaret Rosenfeld, Oscar H. Mayer, et al.. (2011). Analysis of the associations between lung function and clinical features in preschool children with Cystic Fibrosis. Pediatric Pulmonology. 47(6). 574–581. 27 indexed citations

Davis, Stephanie D., Margaret Rosenfeld, Gwendolyn S. Kerby, et al.. (2010). Multicenter Evaluation of Infant Lung Function Tests as Cystic Fibrosis Clinical Trial Endpoints. American Journal of Respiratory and Critical Care Medicine. 182(11). 1387–1397. 77 indexed citations

Gibson, Ronald L., Julia Emerson, Nicole Mayer‐Hamblett, et al.. (2007). Duration of treatment effect after tobramycin solution for inhalation in young children with cystic fibrosis. Pediatric Pulmonology. 42(7). 610–623. 78 indexed citations

Hiatt, Peter, Alan M. Jewell, Stanley G. Cron, et al.. (2006). Human metapneumovirus and respiratory syncytial virus infections in older children with cystic fibrosis. Pediatric Pulmonology. 42(1). 66–74. 24 indexed citations

Gibson, Ronald L., Julia Emerson, Sharon McNamara, et al.. (2003). Significant Microbiological Effect of Inhaled Tobramycin in Young Children with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 167(6). 841–849. 243 indexed citations

10.

Piedra, Pedro A., Stanley G. Cron, Alan M. Jewell, et al.. (2003). Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-center trial in children with cystic fibrosis. Vaccine. 21(19-20). 2448–2460. 72 indexed citations

11.

Ernst, Robert K., David A. D’Argenio, Jeffrey K. Ichikawa, et al.. (2003). Genome mosaicism is conserved but not unique in Pseudomonas aeruginosa isolates from the airways of young children with cystic fibrosis. Environmental Microbiology. 5(12). 1341–1349. 75 indexed citations

12.

Rosenfeld, Margaret, Ronald L. Gibson, Sharon McNamara, et al.. (2001). Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis*. Pediatric Pulmonology. 32(5). 356–366. 304 indexed citations

13.

Burns, Jane L., Ronald L. Gibson, Sharon McNamara, et al.. (2001). Longitudinal Assessment ofPseudomonas aeruginosain Young Children with Cystic Fibrosis. The Journal of Infectious Diseases. 183(3). 444–452. 437 indexed citations

14.

Mak, Grace Z., et al.. (2000). T-Tube ileostomy for meconium ileus: Four decades of experience. Journal of Pediatric Surgery. 35(2). 349–352. 24 indexed citations

15.

Hiatt, Peter, et al.. (1999). Effects of Viral Lower Respiratory Tract Infection on Lung Function in Infants With Cystic Fibrosis. PEDIATRICS. 103(3). 619–626. 155 indexed citations

16.

Piedra, Pedro A., et al.. (1998). Sequential annual administration of purified fusion protein vaccine against respiratory syncytial virus in children with cystic fibrosis. The Pediatric Infectious Disease Journal. 17(3). 217–224. 37 indexed citations

17.

Piedra, Pedro A., et al.. (1996). Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis. The Pediatric Infectious Disease Journal. 15(1). 23–31. 112 indexed citations

18.

Lapin, Craig, et al.. (1993). A lamb model for human respiratory syncytial virus infection.. Pediatric Pulmonology. 15(3). 151–156. 20 indexed citations

19.

Hiatt, Peter. (1992). Identifying and Encouraging Leadership Potential: Assessment Technology and the Library Profession. Library trends. 40(3). 513–542. 2 indexed citations

20.

Hiatt, Peter, Lynn Mahony, & Robert S. Tepper. (1992). Oxygen desaturation during sleep in infants and young children with congenital heart disease. The Journal of Pediatrics. 121(2). 226–232. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact